Editorial: bezafibrate in the treatment of patients with primary biliary cholangitis—are we there yet? Authors' reply

LINKED CONTENT This article is linked to Sorda et al papers. To view these articles, visit https://doi.org/10.1111/apt.16618 and https://doi.org/10.1111/apt.16657

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2022-01, Vol.55 (2), p.249-250
Main Authors: Sorda, Juan Antonio, González Ballerga, Esteban, Barreyro, Fernando Javier, Daruich, Jorge
Format: Article
Language:English
Subjects:
Bezafibrate
Bezafibrate - therapeutic use
Cholangitis
Cholangitis - chemically induced
Cholangitis - drug therapy
Humans
Liver Cirrhosis, Biliary - drug therapy
Ursodeoxycholic Acid
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:LINKED CONTENT This article is linked to Sorda et al papers. To view these articles, visit https://doi.org/10.1111/apt.16618 and https://doi.org/10.1111/apt.16657
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.16726